HOME >> BIOLOGY >> NEWS
Gene expression profiling aids in ovarian cancer prognosis

BOSTON -- The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).

The findings, described in an advance on-line publication of the December issue of the Journal of Clinical Oncology, represent the first time that this type of genetic test has proven useful as a prognostic tool for ovarian cancer, which accounts for approximately 26,000 new cases and 16,000 deaths in the United States each year.

"Ovarian cancer is widely recognized as being extremely difficult to treat," explains Stephen A. Cannistra, M.D., Director of Gynecologic Medical Oncology at BIDMC and Associate Professor of Medicine at Harvard Medical School. "Because symptoms often do not appear until the disease has already spread to the upper abdomen, this malignancy is usually not diagnosed until it has reached an advanced stage." At that point, he adds, doctors typically use clinical data such as the amount of residual disease remaining following surgery to assess a patient's prognosis and determine their course of therapy, a method that Cannistra notes is admittedly imperfect.

Knowing that the behavior of cancers is partly dependent upon which genes are turned on and off in tumor cells, researchers have long suspected that a better understanding of the genetic profile of the tumors of individual patients could help in making a more accurate prognosis.

"With the advent of microarray analysis -- in which genes expressed by the cancer cells are labeled with a probe and then applied to a glass slide that contains embedded sequences of thousands of known human genes this type of genetic information has become much more accessible," explains Cannistra. "[Throug
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
18-Nov-2004


Page: 1 2 3

Related biology news :

1. A low expression of MX2 gene exists in the white blood cells of narcoleptics
2. Gene expression pattern could lead to improved treatment of pediatric septic shock
3. Boston Univeristy bioengineers devise dimmer swith to regulate gene expression in mammal cells
4. Clocking in and out of gene expression
5. High cholesterol diets modify gene expression in atherosclerosis
6. Gene expression patterns predict rapid decline in idiopathic pulmonary fibrosis patients
7. Decoding gene expression in cancer tumors using noninvasive imaging
8. Growing nerve cells in 3-D dramatically affects gene expression
9. XDx to present recent success with AlloMap molecular expression testing
10. Fat tissue-derived hormone leptin increases e-cadherin expression, obesity-breast cancer link noted
11. Clues to gene expression in cystic fibrosis will guide research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
(Date:10/9/2017)... (PRWEB) , ... October 09, ... ... published on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s ... the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using ...
(Date:10/6/2017)... ... 2017 , ... On Tuesday, October 24th, ABC² (Accelerate Brain ... adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. Brian ... to the public, but registration is required. , WHAT: ABC² Brain Cancer ...
Breaking Biology Technology:
Cached News: